Regulatory bodies such as the FDA in the U.S., the EMA in Europe, and Health Canada recognize RWE as a valuable addition to clinical trial data, particularly for safety and effectiveness assessments. Institutions like NICE in the UK, NMPA in China, and the PMDA in Japan also integrate RWE into healthcare guidelines and post-market evaluations, helping support evidence-based healthcare worldwide. Ciencia Research’s RWE solutions help meet the standards of these global agencies, supporting regulatory submissions and healthcare decision-making.
For more information on each agency’s approach to RWE, you can visit:
FDA Real-World Evidence
EMA Real-World Evidence Guidelines
Health Canada Real-World Evidence Framework
NICE Real-World Data Framework
NMPA guiding principles for RWE research
PMDA Real-World Data and Real-World Evidence
RWE regulatory landscapes in Asia-Pacific region
Learn more about Ciencia Research’s regulatory-grade services here.